Each study is conducted under strict adherence to ICH & FDA GCPs, dedicated to a high level of protocol compliance and responsive to critical communication between sponsor, IRB, clinical personnel and related trial entities.

IPRC clinical preparedness benefits the sponsor in accelerating the study startup and expediting the processing for regulatory submission.

IPRC has a dedicated clinical unit with the capacity to On-site accommodation (ambulatory studies) or to provide ready access to local hospital facilities.